Document is current
Any future updates will be listed below
-
Authors
Zapata-Arriaza, Elena http://orcid.org/0000-0002-1730-1999
Medina-Rodríguez, Manuel
Moniche Álvarez, Francisco
de Albóniga-Chindurza, Asier
Aguilar-Pérez, Marta
Ainz-Gómez, Leire
Baena-Palomino, Pablo
Zamora, Aynara
Pardo-Galiana, Blanca
Delgado-Acosta, Fernando
Valverde Moyano, Roberto
Jiménez-Gómez, Elvira
Bravo Rey, Isabel
Oteros Fernández, Rafael
Escudero-Martínez, Irene
Vielba-Gomez, Isabel
Morales Caba, Lluis
Díaz Pérez, Jose
García Molina, Estefania
Mosteiro, Sonia
Castellanos Rodrigo, María del Mar
Amaya Pascasio, Laura
Hidalgo, Carlos
Freijo Guerrero, María del Mar
González Díaz, Eva
Ramírez Moreno, Jose María
Fernández Prudencio, Luis
Terceño Izaga, Mikel
Bashir Viturro, Saima
Gamero-García, Miguel Ángel
Jiménez Jorge, Silvia
Rosso Fernández, Clara
Montaner, Joan
González García, Alejandro
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI21/01322)
- License Information
-
More Information
Article History
Received: 12 July 2023
Accepted: 21 November 2023
First Online: 9 January 2024
Declarations
:
: The Seville Provincial Drug Research Ethics Committee issued FAVORABLE dictum at the meeting held on February 10, 2022 (act number 03/2022). Informed consent by the patient or relatives has to be obtained before trial inclusion.
: The authors declare no competing interests.
